Biopreservation Market Size, Share, Scope Report 2026 to 2035
What is Biopreservation Market Size?
Biopreservation Market Size is valued at USD 4.722.30 Mn in 2025 and is predicted to reach USD 15,127.14 Mn by the year 2035 at a 12.5% CAGR during the forecast period for 2026 to 2035.
Biopreservation Market Size, Share & Trends Analysis Distribution by Product (Media, Equipment’s), By Application (Research Applications, Therapeutic Applications, Other Applications), By End User (Biobanks and Genebanks, Hospitals, Pharmaceutical & Biotech Companies, Contract Research Organizations (CROs), Others (Private Clinics, Academic Institutions, Government)) and Segment Forecasts, 2026 to 2035
Biopreservation refers to the methods and technologies used to keep biological materials—such as cells, tissues, and organs—alive, structurally intact, and functional over time. This is achieved through techniques like cryopreservation (freezing at ultra-low temperatures) and hypothermic storage (cooling without freezing), along with specialized preservation solutions and storage systems.
Numerous applications, including as biobanking, regenerative medicine, cell and gene therapy, drug development, and clinical research, depend heavily on biopreservation. It guarantees the sustained availability of superior biological materials, which are necessary for precise research results, the creation of treatments, and transplantation processes.
The market for biopreservation has been continuously developing because to increased investments in life sciences research, the growing need for biobanking infrastructure, and the growing use of cutting-edge treatments like gene and cell therapies. The growing number of clinical trials and the requirement for uniform biological sample processing and storage further bolster the market. Technological developments in automation, cryogenic storage, and preservation medium have improved dependability and efficiency, which has fueled industry expansion. Nonetheless, elements including the high price of sophisticated equipment, complicated regulations, and difficulties in preserving sample integrity over time still have an impact on market dynamics. All things considered, the market is experiencing significant growth, bolstered by the broadening spectrum of biological research and personalized treatment.
Competitive Landscape
Which are the Leading Players in the Biopreservation Market?
• BioLife Solutions, Inc.
• Thermo Fisher Scientific Inc.
• Sartorius AG
• Azenta, Inc.
• Bio-Techne
• Cryoport Systems, LLC
• Danaher Corporation (Cytiva)
• PHC Corporation
• Alpha Teknova, Inc.
• Eppendorf SE
• ThermoGenesis
• OriGen Biomedical, Inc.
• X-Therma, Inc.
• STEMCELL Technologies
• IC Biomedical, LLC
Market Dynamics
Driver
Rising Adoption of Cell and Gene Therapies
The increasing adoption of cell and gene therapies has emerged as a major driver for the biopreservation market. These advanced therapies rely on the collection, storage, and transportation of living cells, which must remain viable and functionally intact throughout the treatment lifecycle. Biopreservation technologies, particularly cryopreservation and specialized media, play a critical role in ensuring the stability and efficacy of these biological materials from manufacturing to clinical application. As the pipeline of cell and gene therapies continues to expand and more therapies move toward commercialization, the demand for reliable and standardized preservation solutions is rising significantly, thereby driving sustained growth in the biopreservation market.
Restrain/Challenge
High Cost and Technical Complexity of Biopreservation Systems
One of the major challenges in the biopreservation market is the high cost and technical complexity associated with advanced preservation systems. Effective biopreservation requires specialized equipment such as ultra-low temperature freezers, cryogenic storage systems, and controlled-rate freezers, along with high-quality preservation media. These systems involve significant capital investment, ongoing maintenance costs, and strict operational requirements to ensure sample integrity. Additionally, maintaining precise temperature conditions, preventing contamination, and minimizing sample degradation over time demand skilled personnel and standardized protocols. This combination of high costs and technical barriers can limit adoption, particularly among smaller research facilities and in emerging markets, thereby posing a key constraint on overall market growth.
Media Segment is Expected to Drive the Biopreservation Market
The media segment is the primary driver of the biopreservation market. This dominance is attributed to its critical and recurring role in preserving the viability and functionality of biological samples such as cells, tissues, and organs. Unlike equipment, which involves one-time capital investment, preservation media is consumed continuously across biobanking, cell and gene therapy workflows, and research activities, leading to consistent demand. Additionally, the increasing complexity of advanced therapies has driven the need for specialized and optimized media formulations that enhance cell stability during freezing, storage, and thawing processes. As the volume of biological sample handling and clinical applications continues to rise, the media segment remains central to market growth due to its essential and high-frequency usage.
Therapeutic Applications Segment is Growing at the Highest Rate in the Biopreservation Market
The therapeutic applications segment is expected to be the fastest-growing segment in the biopreservation market. This growth is primarily driven by the rapid advancement and commercialization of cell and gene therapies, regenerative medicine, and stem cell-based treatments. These applications require highly reliable biopreservation solutions to maintain the viability and functionality of biological materials throughout processing, storage, and clinical use. Additionally, the increasing number of clinical trials and regulatory approvals for advanced therapies is further accelerating demand for preservation technologies in therapeutic settings. As healthcare continues to shift toward personalized and precision medicine, the therapeutic applications segment is projected to witness significant expansion compared to research and other applications.
Why North America Led the Biopreservation Market?
The market for biopreservation is dominated by North America. The existence of a solid biobanking infrastructure, substantial funding for biotechnology and life sciences research, and early adoption of cutting-edge technologies like gene and cell therapies are the main factors contributing to this dominance. Along with strong clinical research activity, the area also benefits from a significant concentration of pharmaceutical and biotechnology companies. The need for cutting-edge biopreservation technologies has also been bolstered by favorable regulatory frameworks and substantial funding for biomedical research and regenerative medicine. Consequently, North America is still at the top of the worldwide biopreservation industry.
Biopreservation Market Report Scope:
| Report Attribute | Specifications |
| Market size value in 2025 | USD 4,722.30 Mn |
| Revenue forecast in 2035 | USD 15,127.14 Mn |
| Growth Rate CAGR | CAGR of 12.5% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Product Type, Application, End-User and By Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | BioLife Solutions, Inc., Thermo Fisher Scientific Inc., Sartorius AG, Azenta, Inc., Bio-Techne, Cryoport Systems, LLC, Danaher Corporation (Cytiva), PHC Corporation, Alpha Teknova, Inc., Eppendorf SE, ThermoGenesis, OriGen Biomedical, Inc., X-Therma, Inc., STEMCELL Technologies, IC Biomedical, LLC |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Market Segmentation:
Biopreservation Market by Product -
• Media
• Equipment’s
Biopreservation Market by Application -
• Research Applications
• Therapeutic Applications
• Other Applications
Biopreservation Market by End User-
• Biobanks and Genebanks
• Hospitals
• Pharmaceutical & Biotech Companies
• Contract Research Organizations (CROs)
• Others (Private Clinics, Academic Institutions, Government)
Biopreservation Market by Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Biopreservation Market Size is valued at USD 4.722.30 Mn in 2025 and is predicted to reach USD 15,127.14 Mn by the year 2035
Biopreservation Market is expected to grow at a 12.5% CAGR during the forecast period for 2026 to 2035.
BioLife Solutions, Inc., Thermo Fisher Scientific Inc., Sartorius AG, Azenta, Inc., Bio-Techne, Cryoport Systems, LLC, Danaher Corporation (Cytiva), PHC Corporation, Alpha Teknova, Inc., Eppendorf SE, ThermoGenesis, OriGen Biomedical, Inc., X-Therma, Inc., STEMCELL Technologies, IC Biomedical, LLC
Biopreservation Market is segmented into Product Type, Application, End-User and By Region
North America region is leading the Biopreservation Market.